Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.12
Previous CloseN/A
Volume167.40K
Average Volume (3M)511.69K
Market Cap
AU$18.43M
Enterprise ValueAU$29.57
Total Cash (Recent Filing)AU$3.14M
Total Debt (Recent Filing)AU$6.48M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding752,325,800
10 Day Avg. Volume389,011
30 Day Avg. Volume511,693
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)4.98
Price to Sales (P/S)1.62
P/FCF Ratio-2.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.06Price Target Upside100.00% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$23.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Compact X-ray TechnologyA proprietary cold cathode platform can support differentiated imaging products where size, weight and power consumption matter. If successfully commercialised, the technology may underpin multiple product generations and create longer-term OEM or licensing opportunities.
Long-term Revenue Scale-upDespite recent declines, revenue has expanded substantially over the five-year period, indicating the company has increased commercial scale and customer activity. A larger installed and customer base could provide a foundation for future product adoption and recurring support revenue.
Diversified Imaging ApplicationsExposure to medical, security and defence imaging reduces reliance on a single end market and broadens potential use cases for the core X-ray platform. This application diversity can improve the company’s ability to pursue structural demand for compact imaging systems.
Bears Say
Persistent Unprofitable OperationsLarge recurring losses show that revenue growth has not yet translated into a sustainable operating model. Unless product volumes, pricing or costs improve materially, continued losses could constrain investment, weaken negotiating power and require additional funding.
Ongoing Cash BurnPersistent negative operating and free cash flow means the business is not funding its activities internally. Continued cash burn increases dependence on external capital or financing capacity, potentially limiting strategic flexibility and creating dilution or refinancing risk.
Eroding Equity And Rising LeverageThe shrinking equity base and higher debt-to-equity ratio reduce balance-sheet resilience while losses continue. Lower financial flexibility may make it harder to fund development, absorb operational setbacks or secure favourable financing without shareholder or creditor costs.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.02 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$18.43M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Feb 26, 2027 which is in 173 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Aug 27, 2026. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of AU$0 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 752,325,800 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of AU$0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.06 (100.00% Upside)
AU$0.06 (100.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.79%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.81%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions. The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.06
▲(100.00% Upside)
Technical Analysis
Compumedics Limited
―
Cyclopharm Limited
―
EMvision Medical Devices Ltd.
―
4DMedical Ltd
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―